WHAT'S NEXT IN ADVANCED, PREVENTIVE CARDIAC CARE
American Heart Association – Scientific Sessions 2024
BOOTH 5 | Health Innovation Pavilion
Join us at AHA 2024
As a leader in AI-applied cardiac technology, Cleerly is proud to participate in the American Heart Association’s annual exchange of ideas, research, and innovation to accelerate novel solutions in cardiology and reduce the high number of preventable heart attacks.
Learn more about Cleerly’s mission and technology in our presentations throughout the conference. Demos of our digital care pathway will be available at booth 5 in the Health Innovation Pavilion. Cleerly team members are also taking one-on-one meetings.
Fill out the form to request your time slot before the event!
AHA Scientific Sessions 2024
McCormick Place, Chicago
Visit us at:
BOOTH 5
Healthcare Innovation Pavilion
Schedule Now
Join Cleerly at These AHA Sessions and Events
Saturday, November 16
9:45 – 11:00 AM
S103BC
Abstract Oral Presentation
Sex-Specific Coronary Plaque Characteristics and Risk of Cardiovascular Events: Insights from the ISCHEMIA Trial
10:45 - 10:55 AM
Suvasini Lakshmanan, MD, MS
9:45 – 11:00 AM
Membership Lounge (Science and Technology Hall, South Building, Level 3)
Panel Participant
There’s no one path in cardiology. Your interests, creativity, and innovative spirit will take you where you want. This session will expose you to the diverse nonclinical career paths in pharma, health technology, health policy and health administration to highlight just a few. How can you become a health tech innovator? How can you collaborate with industry? Hear from those who’ve paved the path.
James K. Min, MD, MSCCT
11:10 AM – 12:35 PM
Zone 4, Moderated Digital Poster 23
Moderated Digital Poster Session
Revascularization of patients with low-density non-calcified plaque was associated with lower occurrence of acute coronary syndrome
12:00 - 12:05 PM
Shant Malkaisan, MD
Sunday, November 17
3:15 – 4:15 PM
Zone 3
Abstract Poster Session
Age- and Sex-Related Coronary Atherosclerosis by Artificial Intelligence Quantitative Coronary CT Angiography from the INVICTUS Registry
Ryo Okubo, PhD
Monday, November 18
9:30 – 10:45 AM
Zone 2, Moderated Digital Poster 8
Moderated Digital Poster Session
Distribution of Coronary Artery Plaque Volume by Artificial Intelligence Quantitative Coronary CT Angiography in general population: Results from the Miami Heart Study
10:20 - 10:25 AM
Keishi Ichikawa, MD, PhD
AHA Scientific Sessions 2024,
McCormick Place, Chicago
Visit us at:
BOOTH 5
Healthcare Innovation Pavilion
Schedule Now
Patents
Cleerly continues to revolutionize heart attack and cardiovascular disease prevention and treatment everyday by inventing world-class technology. Cleerly invests significant time and resources in research and development towards this goal. To protect Cleerly’s research and development efforts, Cleerly has vigorously developed a robust intellectual property portfolio – all part of a strategy for protecting the innovations that make Cleerly an industry leader in cardiovascular disease prevention and treatment.
Cleerly’s products and services may be covered by or for use under one or more of U.S. Patent Nos. 11,922,627, 11,948,301, 12,023,190, 11,861,833, 11,967,078, 11,832,982, 11,690,586, 11,779,292, 11,730,437, 11,672,497, 11,737,718, 11,751,826, 11,660,058, 11,896,415, 11,751,830, 11,751,829, 11,302,001, 11,308,617, 11,238,587, 11,302,002, 11,321,840, 11,341,644, 11,244,451, 11,288,799, 11,276,170, 11,210,786, 11,232,564, 11,367,190, 11,315,247, 11,969,280, 11,094,060, 11,120,550, 11,120,549, 11,132,796, 11,094,061, 11,113,811, 11,501,436, 11,751,831, 11,642,092, 11,759,161, 11,317,883, 11,350,899, 11,766,230, 11,766,229, and 10,813,612, as well as other patents that are pending.
For additional information, please contact legal@cleerlyhealth.com.